Stem-Cell
Research Hints at Better Looking Cosmetic and Reconstructive Surgery
ARLINGTON, Va., Feb. 17, 2005---Stem-cell researchers have
shown how cosmetic surgery, such as wrinkle removal and breast
augmentation, might be improved with natural implants that keep
their original size and shape better than synthetics.
Cosmetic surgery might be performed with stem-cell generated
natural tissues instead of synthetic implants. Saline and silicone
implants for breast augmentation may rupture, leak, and interfere
with breast cancer detection on mammograms. stem-cell generated
natural tissue implants should avoid these problems.
Reconstructive surgery to replace tissues lost to cancer or
other disease could benefit from stem-cell generated natural
implants that do not shrink or lose their shape. Studies have
shown that conventional soft tissue implants can lose 40 percent
to 60 percent of their volume over time. Examples are breast
tissue reconstruction after breast cancer surgery and facial
soft tissue reconstruction following cancer or trauma surgeries.
Natural implants often require separate surgical procedures
from a healthy location of the patient's body to obtain tissue
for constructing the implant. The stem-cell approach does not
require extensive surgery because cells needed for the implant
are obtained in a less invasive needle procedure.
Whitaker investigator Jeremy Mao, Ph.D., of the University
of Illinois at Chicago presented his results at the annual meeting
of the American Association for the Advancement of Science in
Washington, D.C., saying that a stem-cell approach might eliminate
the need for the additional surgery and may produce a long-lasting,
shapely, and natural implant. The research will also be published
in April in the journal Tissue Engineering.
Mao's research group started with a line of human stem cells
taken from the bone marrow of a healthy, young volunteer. These
mesenchymal stem cells can transform themselves into many different
cell types under appropriate conditions, including those that
form cartilage, bone, and fat. In this case, the stem cells
were grown with substances that encouraged them to become fat-producing
cells.
Cells from this culture were placed in a Food and Drug Administration-approved
scaffold that mimics the natural environment in which fat cells
grow in the body. The hydrogel scaffold can be molded into any
shape or size. These cell seeded scaffolds were placed under
the skin in eight laboratory mice. After four weeks, the implants
were removed and examined.
The researchers found that the stem cells had differentiated
into fat generating cells and the implant had retained both
its original size and shape. Conventional implants begin to
lose shape within a few weeks, so Mao's group was encouraged
by the fact that their implants retained their original dimensions
for a month.
These results demonstrate the potential of using such an approach
in medical applications. But more, longer term studies will
be needed and many questions remain to be answered. Further
research is needed on the density of cells used in the culture,
the rate at which the scaffold degrades, the relationship between
the implant and existing host tissues, and whether any additional
growth factors will be required to ensure that the implant develops
a healthy and lasting blood supply.
"Nonetheless, the present approach represents another
step toward an alternative tissue engineering approach for soft
tissue augmentation and reconstruction," the researchers
reported.
Mao's colleagues include Adel Alhadlaq and Minghui Tang of
the University of Illinois at Chicago. The research was supported
by grants from the National Institute of Dental and Craniofacial
Research and the National Institute of Biomedical Imaging and
Bioengineering at the National Institutes of Health.
Mao received a Whitaker Biomedical Engineering Research grant
in 2002 for this line of work. In ongoing research, he has used
adult stem cells to grow cartilage
and bone in the shape of a human joint end, a potential
medical implant for orthopedic and reconstructive surgeries.
Contact:
Jeremy Mao, University of
Illinois at Chicago
Frank Blanchard, The
Whitaker Foundation
|